106 related articles for article (PubMed ID: 8528052)
1. Cytofluorimetric and functional analysis of c-kit receptor in acute leukemia.
Lauria F; Bagnara GP; Rondelli D; Raspadori D; Strippoli P; Bonsi L; Ventura MA; Montanaro LL; Bubola G; Tura S
Leuk Lymphoma; 1995 Aug; 18(5-6):451-5. PubMed ID: 8528052
[TBL] [Abstract][Full Text] [Related]
2. AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression.
Reuss-Borst MA; Bühring HJ; Schmidt H; Müller CA
Leukemia; 1994 Feb; 8(2):258-63. PubMed ID: 7508533
[TBL] [Abstract][Full Text] [Related]
3. CD117/CD34 expression in leukemic blasts.
Wells SJ; Bray RA; Stempora LL; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
[TBL] [Abstract][Full Text] [Related]
4. Changes in phenotype and proliferative potential of human acute myeloblastic leukemia cells in culture with stem cell factor.
Ikeda H; Kanakura Y; Furitsu T; Kitayama H; Sugahara H; Nishiura T; Karasuno T; Tomiyama Y; Yamatodani A; Kanayama Y
Exp Hematol; 1993 Dec; 21(13):1686-94. PubMed ID: 7694869
[TBL] [Abstract][Full Text] [Related]
5. Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells.
Ikeda H; Kanakura Y; Tamaki T; Kuriu A; Kitayama H; Ishikawa J; Kanayama Y; Yonezawa T; Tarui S; Griffin JD
Blood; 1991 Dec; 78(11):2962-8. PubMed ID: 1720040
[TBL] [Abstract][Full Text] [Related]
6. The c-kit molecule and the surface immunophenotype of human acute leukemia.
Kubota A; Okamura S; Shimoda K; Harada M; Niho Y
Leuk Lymphoma; 1994 Aug; 14(5-6):421-8. PubMed ID: 7529077
[TBL] [Abstract][Full Text] [Related]
7. Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance.
Schwartz S; Heinecke A; Zimmermann M; Creutzig U; Schoch C; Harbott J; Fonatsch C; Löffler H; Büchner T; Ludwig WD; Thiel E
Leuk Lymphoma; 1999 Jun; 34(1-2):85-94. PubMed ID: 10350335
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
[TBL] [Abstract][Full Text] [Related]
9. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
[TBL] [Abstract][Full Text] [Related]
10. High expression of c-kit mRNA predicts unfavorable outcome in adult patients with t(8;21) acute myeloid leukemia.
Gao X; Lin J; Gao L; Deng A; Lu X; Li Y; Wang L; Yu L
PLoS One; 2015; 10(4):e0124241. PubMed ID: 25860287
[TBL] [Abstract][Full Text] [Related]
11. Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow.
Ashman LK; Cambareri AC; To LB; Levinsky RJ; Juttner CA
Blood; 1991 Jul; 78(1):30-7. PubMed ID: 1712644
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody YB5.B8 identifies the human c-kit protein product.
Lerner NB; Nocka KH; Cole SR; Qiu FH; Strife A; Ashman LK; Besmer P
Blood; 1991 May; 77(9):1876-83. PubMed ID: 1708291
[TBL] [Abstract][Full Text] [Related]
14. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
15. C-kit receptor (CD117) expression in acute leukemia.
Valverde LR; Matutes E; Farahat N; Heffernan A; Owusu-Ankomah K; Morilla R; Catovsky D
Ann Hematol; 1996 Jan; 72(1):11-5. PubMed ID: 8605274
[TBL] [Abstract][Full Text] [Related]
16. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.
Ludescher C; Eisterer W; Hilbe W; Gotwald M; Hofmann J; Zabernigg A; Cianfriglia M; Thaler J
Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774
[TBL] [Abstract][Full Text] [Related]
17. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical value of SHP-1 and c-kit in acute leukemia].
Han Y; Luo JM; Jia XH; Wang FX; Yao L; DU XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):867-71. PubMed ID: 17096878
[TBL] [Abstract][Full Text] [Related]
19. Immobilized anti-KIT monoclonal antibody induces ligand-independent dimerization and activation of Steel factor receptor: biologic similarity with membrane-bound form of Steel factor rather than its soluble form.
Kurosawa K; Miyazawa K; Gotoh A; Katagiri T; Nishimaki J; Ashman LK; Toyama K
Blood; 1996 Mar; 87(6):2235-43. PubMed ID: 8630383
[TBL] [Abstract][Full Text] [Related]
20. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry].
Xu B; Hu C; Miao XD; Wu YH; Yi ZS; Yang Y; Meng FY; Feng R; Liu QF; Liu XL; Zheng WY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1043-6. PubMed ID: 14559689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]